Diagnosis of the Zollinger-Ellison Syndrome

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 2, 2012, Pages 126-130

  Metz, David C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; GASTRIN; OMEPRAZOLE;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG DOSE INCREASE; GASTRIN BLOOD LEVEL; HEARTBURN; HUMAN; MAINTENANCE DRUG DOSE; MALE; PROTEIN BLOOD LEVEL; ZOLLINGER ELLISON SYNDROME;

ADULT; ENDOSCOPY, GASTROINTESTINAL; GASTRINS; HUMANS; MALE; PROTON PUMP INHIBITORS; ZOLLINGER-ELLISON SYNDROME;

EID: 84856032353     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.07.012     Document Type: Article

References (35)

1. Zollinger R.M., Ellison E.H. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955, 142:709-723. discussion, 724-728.
2. Metz D.C., Jensen R.T. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 2008, 135:1469-1492.
3. Waxman I., Gardner J.D., Jensen R.T., et al. Peptic ulcer perforation as the presentation of Zollinger-Ellison syndrome. Dig Dis Sci 1991, 36:19-24.
4. Stage J.G., Stadil F. The clinical diagnosis of the Zollinger-Ellison syndrome. Scand J Gastroenterol Suppl 1979, 53:79-91.
5. Corleto V.D., Annibale B., Gibril F., et al. Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome?. Aliment Pharmacol Ther 2001, 15:1555-1561.
6. Maton P.N., Frucht H., Vinayek R., et al. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study. Gastroenterology 1988, 94:294-299.
7. Weber H.C., Venzon D.J., Lin J.T., et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995, 108:1637-1649.
8. Norton J.A., Fraker D.L., Alexander H.R., et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999, 341:635-644.
9. Norton J.A., Fraker D.L., Alexander H.R., et al. Surgery increases survival in patients with gastrinoma. Ann Surg 2006, 244:410-419.
10. Fishbeyn V.A., Norton J.A., Benya R.V., et al. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach. Ann Intern Med 1993, 119:199-206.
11. Norton J.A., Jensen R.T. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg 2004, 240:757-773.
12. Wilcox C.M., Seay T., Arcury J.T., et al. Zollinger-Ellison syndrome: presentation, response to therapy, and outcome. Dig Liver Dis 2011, 43:439-443.
13. Rehfeld J.F., Gingras M.H., Bardram L., et al. The Zollinger-Ellison syndrome and mismeasurement of gastrin. Gastroenterology 2011, 140:1444-1453.
14. Stabile B.E., Morrow D.J., Passaro E. The gastrinoma triangle: operative implications. Am J Surg 1984, 147:25-31.
15. Schubert M.L., Peura D.A. Control of gastric acid secretion in health and disease. Gastroenterology 2008, 134:1842-1860.
16. McColl K.E., el-Omar E., Gillen D. Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. Br Med Bull 1998, 54:121-138.
17. Metz D.C., Weber H.C., Orbuch M., et al. Helicobacter pylori infection. A reversible cause of hypergastrinemia and hyperchlorhydria which may mimic Zollinger-Ellison syndrome. Dig Dis Sci 1995, 40:153-159.
18. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
19. Dhillo W.S., Jayasena C.N., Lewis C.J., et al. Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists. Ann Clin Biochem 2006, 43:153-155.
20. Wolfe M.M., Jensen R.T. Zollinger-Ellison syndrome. Current concepts in diagnosis and management. N Engl J Med 1987, 317:1200-1209.
21. Berna M.J., Hoffmann K.M., Serrano J., et al. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. Medicine (Baltimore) 2006, 85:295-330.
22. Borch K., Renvall H., Liedberg G., et al. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol 1986, 21:357-363.
23. Kuipers E.J., Lundell L., Klinkenberg-Knol E.C., et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996, 334:1018-1022.
24. Sachs G., Shin J.M., Howden C.W. Review article: the clinical pharmacology of proton pump inhibitors. Aliment Pharmacol Ther 2006, 23(Suppl 2):2-8.
25. Metz D.C., Pisegna J.R., Fishbeyn V.A., et al. Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome. World J Surg 1993, 17:468-480.
26. Pratha V.S., Hogan D.L., Lane J.R., et al. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults. Dig Dis Sci 2006, 51:123-131.
27. Roy P.K., Venzon D.J., Feigenbaum K.M., et al. Gastric secretion in Zollinger-Ellison syndrome. Correlation with clinical expression, tumor extent and role in diagnosis-a prospective NIH study of 235 patients and a review of 984 cases in the literature. Medicine (Baltimore) 2001, 80:189-222.
28. Frucht H., Howard J.M., Slaff J.I., et al. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study. Ann Intern Med 1989, 111:713-722.
29. Metz D.C., Buchanan M., Purich E., et al. A randomized controlled crossover study comparing synthetic porcine and human secretins with biologically derived porcine secretin to diagnose Zollinger-Ellison syndrome. Aliment Pharmacol Ther 2001, 15:669-676.
30. Feldman M., Schiller L.R., Walsh J.H., et al. Positive intravenous secretin test in patients with achlorhydria-related hypergastrinemia. Gastroenterology 1987, 93:59-62.
31. Reubi J.C., Häcki W.H., Lamberts S.W. Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab 1987, 65:1127-1134.
32. Gibril F., Reynolds J.C., Chen C.C., et al. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. J Nucl Med 1999, 44:539-553.
33. Norton J.A., Doppman J.L., Jensen R.T. Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study. Ann Surg 1992, 215:8-18.
34. Goebel S.U., Serrano J., Yu F., et al. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer 1999, 85:1470-1483.
35. Vezzosi D., Walter T., Laplanche A., et al. Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up study. Int J Biol Markers 2011, 26:94-101.